BioCentury
ARTICLE | Product Development

Pharma spinouts: a snapshot of where and how pharmas spin out their assets

Pharma spinouts account for small percentage of total newcos, but large share of capital raised

December 20, 2019 5:26 AM UTC
Updated on Dec 20, 2019 at 5:35 AM UTC

The handoff of innovation to academia is all but complete, with universities and other academic institutions accounting for the origin of about 75% of new companies formed in the last three years. But while pharma spinouts account for a small minority of the total, they pack a punch when it comes to financial backing.

Since the start of 2017, 602 companies have announced seed or series A financing...